Alliance for Integrity and Reform of 340B

04/22/2026

MUST READ: Washington Post Opinions is pulling back the curtain on abuse hiding in plain sight. exploitation drives up costs for everyone through consolidation, markups and misaligned incentives. Federal reform is needed so large hospitals stop cashing in on 340B.

A drug discount program has fueled consolidation and incentivized prescribing more expensive medications.

04/15/2026

Filing your taxes today? Don’t forget that 340B is a hidden tax on us all. The program is estimated to have reduced state and federal tax revenue by $17 billion in 2023, and cost Medicaid and Medicare a combined $20B – which raises costs for Americans. Reform is needed to stop the :

Large, tax-exempt hospitals are exploiting a little-known federal program for profit and driving up health care costs for everyone. The […]

04/15/2026

“The financial incentive driving growth in 340B entities and PBMs is spread pricing. Both entities use spread pricing to make huge profits at the expense of patients and taxpayers.” – Pharmacist Jay Norberg highlights how markups and practices are a hidden tax to us all. Federal legislation is necessary to ensure the 340B program benefits patients. Read more in Duluth News Tribune:

From the column: "The spread of 'pharmacy deserts' across Minnesota is no accident. Each ... represents consolidation by corporate health care systems chasing after spread pricing."

04/08/2026

“The growth begs the question – where are the tens of billions of dollars generated by this program coming from, and where are they going?” In Real Clear Health, Neal Masia highlights his recent research confirming that growth is driven by large hospitals, driving independent providers out of business and raising costs for us all:

The 340B Drug Pricing Program was originally intended to ensure that patients at a narrow set of community-based clinics and a handful of hospitals had access to reduced-cost prescription medicines. O

04/02/2026

After facing overwhelmingly high medical bills, Logan Dubay questioned whether the program truly serves patients as intended. After discovering that hospitals use program savings to pad their own profits, he now calls on Congress to strengthen program transparency and accountability. Read more in Detroit News:

A patient's unexpected surgery led to high bills, revealing hospitals may profit from drug discounts meant for patients.

04/01/2026

Breast cancer patient Garrina Ross details how the program fell short of giving her the lifesaving care she needed. Lack of guardrails enable hospitals to maximize revenue through prescription markups and increased consolidation. Patients need real change and real transparency. Read more in Bridge Michigan:

Michigan needs to ensure no entity can misuse 340B, a program meant for patients. Michigan lawmakers have a chance to be leaders in this fight. They must reject proposals like House Bill 4878 that lack real accountability and guardrails.

03/27/2026

AIR340B Member Global Healthy Living Foundation emphasizes how the Minnesota Department of Health 340B Covered Entity Report offers striking insight into the 340B program and urges reform that ensures savings are passed on to patients. Read more in lohud:

New York lawmakers should heed the warning and respond. Real reforms of the 340B program cannot wait.

03/20/2026

Check out a recent blog from AIR340B member Citizens Against Government Waste on how the Minnesota Department of Health Covered Entity Report is clear evidence on why Congress must review and reform the program to ensure it benefits patients as intended. Read more:

The Minnesota Department of Health's latest report sheds light on the growing abuses of the 340B program.

03/13/2026

Check out a study from AIR340B member National Grange revealing that many large, urban hospitals are exploiting loopholes to qualify for 340B discounts, allowing them to divert resources intended to help vulnerable rural communities. Federal 340B reform is critical. Learn more:

HOSPITAL DUAL CLASSIFICATION Hospital Dual Classification The National Grange supported the release of a new analysis by Magnolia Market Access examining how Medicare hospital reclassification policies are increasingly diverting resources intended for rural hospitals to large urban health systems, w...

03/11/2026

New analysis finds that large hospitals are driving program growth. While large hospitals make up 33% of program participants, they account for 81% of new outpatient clinics. Increased 340B expansion means higher costs for us all. Learn more:

Research study showing that the 340B program is increasingly dominated by large hospitals and AMCs.

03/06/2026

MUST READ: report reveals that Minnesota hospitals and clinics generated over $1.3B in program revenue in just one year – but only 12% contributed towards operating expenses. The question remains: Where is the money going? Federal reform is needed to end program abuse and ensure 340B benefits patients. See the findings:

03/05/2026

New National Consumers League analysis shows hospitals are more aggressive in medical debt collection than non-340B hospitals. Despite receiving drug discounts to support vulnerable patients, 75% pursue legal action against them. Learn more:

March 2, 2025: Washington, DC – A new analysis from the National Consumers League (NCL) finds that hospitals participating in the federal 340B Drug Pricing Program—including many hospitals that treat high volumes of cancer patients —are more likely than non-340B hospitals to permit aggressive ...